Squarepoint Ops LLC Has $305,000 Stake in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Squarepoint Ops cut its Acadia Healthcare stake by 94% in the second quarter, selling 162,705 shares and retaining 10,331 shares valued at approximately $305,000.
• Acadia Healthcare reported quarterly EPS of $0.38, topping estimates of $0.35, while revenue of $865.84 million also exceeded expectations. The company maintained fiscal 2026 EPS guidance of $1.45–$1.60.
• Analyst sentiment remains mixed: several firms issued or maintained “buy” ratings, but the overall consensus is “Hold” with an average price target of $29.85.

Squarepoint Ops LLC reduced its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 94.0% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 10,331 shares of the company's stock after selling 162,705 shares during the period. Squarepoint Ops LLC's holdings in Acadia Healthcare were worth $305,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Allworth Financial LP acquired a new stake in shares of Acadia Healthcare in the second quarter valued at about $45,000. Global Retirement Partners LLC bought a new stake in Acadia Healthcare in the second quarter valued at approximately $68,000. Quantbot Technologies LP bought a new stake in Acadia Healthcare in the second quarter valued at approximately $88,000. Teachers Retirement System of The State of Kentucky increased its position in Acadia Healthcare by 5.1% during the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 75,095 shares of the company's stock valued at $1,757,000 after purchasing an additional 3,642 shares during the period. Finally, PNC Financial Services Group Inc. raised its holdings in Acadia Healthcare by 103.5% during the 1st quarter. PNC Financial Services Group Inc. now owns 7,234 shares of the company's stock worth $169,000 after purchasing an additional 3,680 shares during the last quarter.

Acadia Healthcare Trading Up 3.5%

NASDAQ ACHC opened at $29.37 on Wednesday. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. Acadia Healthcare Company, Inc. has a 52 week low of $11.43 and a 52 week high of $35.83. The business has a 50 day moving average price of $30.06 and a 200-day moving average price of $27.29. The company has a market cap of $2.73 billion, a price-to-earnings ratio of -2.36, a P/E/G ratio of 9.14 and a beta of 0.62.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.03. The business had revenue of $865.84 million during the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. Acadia Healthcare's revenue was down .4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, equities analysts expect that Acadia Healthcare Company, Inc. will post 1.55 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ACHC. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Acadia Healthcare in a research note on Wednesday, September 9th. Jefferies Financial Group raised shares of Acadia Healthcare from a "hold" rating to a "buy" rating and lifted their target price for the stock from $24.50 to $30.00 in a research note on Wednesday, June 3rd. UBS Group upped their price target on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a "buy" rating in a research report on Thursday, July 9th. Cantor Fitzgerald reiterated a "neutral" rating on shares of Acadia Healthcare in a report on Wednesday, July 29th. Finally, TD Cowen lifted their price objective on Acadia Healthcare from $30.00 to $36.00 and gave the stock a "buy" rating in a research report on Tuesday, July 14th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, Acadia Healthcare currently has an average rating of "Hold" and an average target price of $29.85.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The company operates facilities that offer treatment for mental health conditions, substance use disorders and other behavioral health needs. Its services are designed for children, adolescents and adults and may include inpatient psychiatric care, residential treatment, outpatient programs and specialized care.

Acadia's facilities provide a range of treatment programs, including psychiatric hospitals, addiction treatment centers, eating disorder programs and other specialty behavioral healthcare services.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.